Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment - Science Daily

Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment Science Daily While target therapies directed toward genetic mutations that drive a tumor's growth have significantly improved the outlook for many patients, they have not been as successful in controlling brain metastases in several types of cancer. In the case of ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qE7bEf
via IFTTT